Viewing nowCombinationValsartan Plus Tablet 80/12.5 mg
Valsartan 80mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Jungheun Pharmaceutical Co., Ltd.

MFDS item code 200807618 · Notified 2008.07.09 · Insurance code 053301090
Treatment of essential hypertension not controlled with monotherapy
This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy. It effectively lowers blood pressure to aid in hypertension management.
○ Adults The recommended dose is 1 tablet of valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken with or without food, with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg is for patients prescribed valsartan 160 mg/hydrochlorothiazide 12.5 mg to lower blood pressure. The maximum blood pressure-lowering effect is reached after 2 ~ 4 weeks. ○ Patients with renal impairment No dose adjustment is necessary for patients with mild to moderate renal impairment (creatinine clearance 30 mL/min or greater). ○ Patients with hepatic impairment In patients with mild to moderate hepatic impairment without cholestasis, do not use more than 80 mg of valsartan per day.
This medication should not be taken during pregnancy, especially in the second and third trimesters, as it can cause serious harm to the fetus; discontinue immediately upon confirmation of pregnancy. People allergic to this drug, its components, or sulfonamide drugs should not take it. Patients with severely impaired liver or kidney function, particularly those with severe liver disease or severe kidney disease, should not take this medication. Patients with excessively low blood pressure or electrolyte imbalances, as well as individuals with certain autoimmune diseases or cardiovascular diseases should use caution when taking this medication. Since this medication lowers blood pressure, dizziness or drowsiness may occur during initial therapy; caution is required during driving or operating machinery. There is a risk of increased potassium levels, so potassium supplements or potassium-rich foods should not be consumed excessively without consulting a physician. This medication may interact with other drugs, particularly lithium, non-steroidal anti-inflammatory drugs (NSAIDs), other antihypertensives, and diabetes medications; follow the doctor's guidance when taking them together. Due to the hydrochlorothiazide component, the skin may become sensitive to sunlight; it is advisable to avoid prolonged sun exposure and to use appropriate sunblock. Regular monitoring of blood pressure, kidney function, and electrolyte levels is necessary during therapy to check for any abnormalities. Overdosage can lead to symptoms such as hypotension, arrhythmias, and electrolyte disturbances, requiring immediate medical attention. Extra caution is needed for children and the elderly; safety in pediatric patients has not been established. This medication should be stored in a tightly closed container away from moisture and direct sunlight, and out of reach of children.
Headache, dizziness, nasopharyngitis, fatigue, lower back pain, cough, upper respiratory tract infection, diarrhea, joint pain, abdominal pain, epigastric pain, blurred vision, visual disturbances, anxiety, arthritis, bronchitis, acute bronchitis, chest pain, orthostatic dizziness, dry mouth, dyspepsia, shortness of breath, erectile dysfunction, enterocolitis, sweating, sensory loss, insomnia, hypokalemia, hypotension, influenza, muscle cramps, myalgia, nausea, nasal congestion, nasal hemorrhage, throat pain, otitis media, limb pain, paresthesia, pharyngodynia, fever, sinus congestion, sinusitis, drowsiness, leg cramps, frequent urination, palpitations, rash, ligament sprain, syncope, tachycardia, tinnitus, urinary tract infection, viral infection, edema, peripheral edema, weakness, angioedema, itching, serum sickness, vasculitis, hair loss, kidney function impairment, myalgia, anaphylactic-like symptoms, hepatitis, renal failure, hyperkalemia, hyponatremia, shock, loss of consciousness, agranulocytosis, leukopenia, thrombocytopenia, aplastic anemia, hemolytic anemia, necrotizing vasculitis, toxic epidermal necrolysis, interstitial pneumonia, pulmonary edema, exacerbation of systemic lupus erythematosus, hypoglycemia, rhabdomyolysis, elevated AST, palpitations, dyspepsia, edema, weakness, hypertriglyceridemia, increased creatine kinase, decreased hemoglobin, decreased hematocrit, elevated serum potassium, dizziness, vasculitis, elevated liver function tests, angioedema, rash, vesicular dermatitis, renal failure, joint pain, weakness, lower back pain, insomnia, decreased libido, nausea, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, viral infection, hypokalemia, elevated blood lipids, hyponatremia, hypomagnesemia, hyperuricemia, hypercalcemia, hypochloremic metabolic alkalosis, hyperglycemia, diabetes, urticaria, skin rash, photosensitive reactions, necrotizing vasculitis, dermato-lupus erythematosus, decreased appetite, vomiting, abdominal discomfort, constipation, gastrointestinal discomfort, pancreatitis, intrahepatic cholestasis, jaundice, orthostatic hypotension, cardiac arrhythmias, sensory loss, sedation, sleep disturbances, depression, paresthesia, visual impairment, thrombocytopenia, leukopenia, agranulocytosis, bone marrow dysfunction, hemolytic anemia, acute respiratory distress syndrome, erectile dysfunction, hypersensitivity reactions, pneumonia, pulmonary edema, acute renal failure, renal impairment, aplastic anemia, erythema multiforme, fever, muscle cramps, acute angle-closure glaucoma, choroidal exudate, nausea, drowsiness, hypovolemia, arrhythmias, muscle rigidity, hypotension, tachycardia
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture, preferably in a cool place below 30 degrees Celsius. This way, the effectiveness of the medication can be maintained for a longer period.
Bright orange oval film-coated tablets
Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle, PTP - 98 tablets/box[14 tablets/PTP*7]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 80mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Jungheun Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Hydrochlorothiazide
Prescription medication · Combination
Sandoz Korea Co., Ltd.
Valsartan · Hydrochlorothiazide
Prescription medication · Combination
Sandoz Korea Co., Ltd.
CombinationValsartan 80mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Anguk Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Anguk Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Albozen Korea Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.